DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lifeflight: Fentanyl Versus Morphine

Information source: MetroHealth Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pain Relief; Adverse Events

Intervention: either fentanyl or morphine (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: MetroHealth Medical Center

Official(s) and/or principal investigator(s):
Michael D Smith, MD, Principal Investigator, Affiliation: MetroHealth Medical Center

Overall contact:
Michael D Smith, MD, Phone: 216-778-5747, Email: msmith2@metrohealth.org


The study is exempt from informed consent by the MetroHealth Medical Center institutional review board (IRB), because two standards of care are used and there is no increased clinical risk to the patient due to the study. The researchers randomize either fentanyl or morphine to be given to trauma patients and record how their pain scale is treated along with observing for adverse events. They are looking to see if the hypothesized benefits of fentanyl (which is much more expensive than morphine) actually exist.

Clinical Details

Official title: Efficacy and Adverse Events of Morphine and Fentanyl in an Aeromedical Setting

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Primary outcome: Relief of pain by numeric pain scale

Secondary outcome: Recording of instance of narcotic side effects (vital sign derangement, itching, nausea/vomiting)

Detailed description: Periodic reports are made to the IRB.


Minimum age: 18 Years. Maximum age: 69 Years. Gender(s): Both.


Inclusion Criteria:

- Trauma patient

- Able to speak/communicate a pain scale

Exclusion Criteria:

- Age <18

- Age >69

- Initially or any time hypotensive

- Prisoner

Locations and Contacts

Michael D Smith, MD, Phone: 216-778-5747, Email: msmith2@metrohealth.org

MetroHealth Medical Center, Cleveland, Ohio 44109, United States; Recruiting
Michael D Smith, MD, Principal Investigator
Additional Information

Starting date: August 2006
Last updated: December 21, 2007

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017